Supporting the fight against cancer
Contributing to the solution
In late 2018, we launched a strategy designed to contribute to the fight against cancer, investing in businesses around the world that develop cancer treatment products and services (including diagnostics, tumour profiling, technologies and treatments). Up to 10% of the yearly net management fees of the fund are earmarked for organisations working in cancer research and prevention, as well as for supporting patients and their families.






